Definitive Contract 75N95023C00019

Award Date 9/15/23
Potential Completion Date 6/14/24
Potential Value $325K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
College Station, TX, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Lynntech Inc., doing business as Lynntech Inc., has been awarded a $1.5 million firm fixed price SBIR Phase II contract from the National Institutes of Health's National Center for Advancing Translational Sciences to research substrate alternatives for organ-on-a-chip applications. The three-year contract will be performed in College Station, Texas and supports the agency's goal of improving human health through innovative translational sciences. As a total small business set-aside, this award...
The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $223,568.00, is for the development of a "Simple, Inexpensive Unit for Removing Cells from Small Amounts of Blood in Resource-Limited Settings." This contract is a Firm Fixed Price...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute, a civilian agency, to Lynntech Inc., a small business technology development company. The $299,984 firm-fixed-price contract is for research and development in the biomedical field, specifically basic research. The contract was set aside for small businesses. Lynntech has extensive experience conducting contracted research and prototype development for various government...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $149,985.00, is designated as a total small business set-aside. The contract is for "OTHER FUNCTIONS" and the ultimate completion date is May 22, 2017. Lynntech has a strong track record of delivering innovative solutions to various U.S. federal...
This is a $149,995 firm fixed-price purchase order contract awarded by the Air Force Research Laboratory (AFRL) to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract is part of the Small Business Innovation Research (SBIR) program and is for Phase I research and development work on "Next Generation Organ-on-a-Chip" technology. The contract has a total small business set-aside designation, indicating it is reserved for small...
This is a $750,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Air Force Research Laboratory (AFRL) to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract is for the development of a "Next Generation Organ on Chip" system, which is designated as a total small business set-aside. Lynntech has extensive experience conducting contracted research and prototype development for various military...
This is a $300,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, titled "CORNAUCOPIA - A METHOD TO DELIVER MULTIPLE BNABS IN THE SAME RNA," is a total small business set-aside with an ultimate completion date of August 14, 2025. Lynntech Inc. has...
This is a Firm Fixed Price contract awarded by the Shared Services Center, a civilian federal agency, to Lynntech Inc., a small business technology company based in College Station, Texas. The contract, valued at $849,999.00, is for the development of a Miniaturized Reagent Regenerative Ion Analyzer for Elemental Analysis under the Small Business Innovation Research (SBIR) Phase II program. This contract is a total small business set-aside, reflecting Lynntech's role in driving innovation within...
This is a $124,820 Firm Fixed Price contract awarded by the National Aeronautics and Space Administration (NASA) to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract falls under the Small Business Technology Transfer (STTR) Phase I program and is for the development of a multi-analyte microfluidic colorimetric sensor for detecting inorganic ions. This total small business set-aside contract has a period of performance ending on June...
This is a DARPA (Defense Advanced Research Projects Agency) Small Business Innovation Research (SBIR) Phase II contract awarded to Lynntech Inc., a small business research and development company. The contract, with a potential value of $1,996,402.00, is for efforts entitled "A High-Throughput Platform to Culture the Unculturables." This SBIR Phase II contract builds upon prior research and is focused on developing innovative technology solutions. SBIR contracts are set-aside for small...

Lynntech Inc. was awarded a $325,000 definitive contract by the National Institutes of Health National Center for Advancing Translational Sciences to develop an automated cell culture flask cleaning instrument. The award was made under a total small business set-aside Small Business Innovation Research solicitation seeking proposals for innovative solutions supporting NIH and CDC missions across cancer, infectious diseases, aging, and public health. Research will be conducted by Lynntech in College Station, Texas over a 9-month period under a firm fixed price contract to advance the National Institutes of Health's efforts in biomedical research.

Generated 12/29/23, 3:32 PM